Data / Form D filings / 65 Therapeutics, Inc.
65 Therapeutics, Inc.: Form D filings
65 Therapeutics, Inc., a pharmaceuticals company in Somerville, MA, filed 2 Form D notices with the SEC between 2024 and 2026. The latest, on July 6, 2026, reports $6.7 million sold of a $6.7 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 399 REVOLUTION DRIVE, Somerville, MA, 02145
- Phone
- (617) 784-9147
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2047647
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Amendment | $6,700,000 | $6,700,000 | 2 | Nov 21, 2024 | sec.gov | |
| Dec 6, 2024 | New notice | $5,500,000 | $4,500,000 | $1,000,000 | 2 | Nov 21, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Julius Knowles | Executive Officer, Director | |
| Murthy Chavali | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jul 6, 2026 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what 65 Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.